150 related articles for article (PubMed ID: 9703900)
1. Uncoupling of incorporation of ascorbic acid and apoptosis induction.
Amano Y; Sakagami H; Tanaka T; Yamanaka Y; Nishimoto Y; Yamaguchi M; Takeda M
Anticancer Res; 1998; 18(4A):2503-6. PubMed ID: 9703900
[TBL] [Abstract][Full Text] [Related]
2. Relationship between ascorbyl radical intensity and apoptosis-inducing activity.
Sakagami H; Satoh K; Ohata H; Takahashi H; Yoshida H; Iida M; Kuribayashi N; Sakagami T; Momose K; Takeda M
Anticancer Res; 1996; 16(5A):2635-44. PubMed ID: 8917363
[TBL] [Abstract][Full Text] [Related]
3. Induction of cell death by ascorbic acid derivatives in human renal carcinoma and glioblastoma cell lines.
Makino Y; Sakagami H; Takeda M
Anticancer Res; 1999; 19(4B):3125-32. PubMed ID: 10652601
[TBL] [Abstract][Full Text] [Related]
4. Ca2+ mobilization during cell death induction by sodium 5, 6-benzylidene-L-ascorbate.
Takahashi H; Sakagami H; Ohata H; Iida M; Momose K; Yamamura M; Takeda M
Anticancer Res; 1996; 16(5A):2629-34. PubMed ID: 8917362
[TBL] [Abstract][Full Text] [Related]
5. Role of hydrogen peroxide for cell death induction by sodium 5,6-benzylidene-L-ascorbate.
Tajima M; Toguchi M; Kanda Y; Kunii S; Hosaka M; Arakawa H; Maeda M; Satoh K; Asano K; Kochi M; Sakagami H
Anticancer Res; 1998; 18(3A):1697-702. PubMed ID: 9673392
[TBL] [Abstract][Full Text] [Related]
6. The interaction between two antioxidants, sodium ascorbate and gallic acid: radical intensity and apoptosis induction.
Sakagami H; Satoh K
Anticancer Res; 1996; 16(3A):1231-4. PubMed ID: 8702242
[TBL] [Abstract][Full Text] [Related]
7. Differential effects and transport kinetics of ascorbate derivatives in leukemic cell lines.
Koh WS; Lee SJ; Lee H; Park C; Park MH; Kim WS; Yoon SS; Park K; Hong SI; Chung MH; Park CH
Anticancer Res; 1998; 18(4A):2487-93. PubMed ID: 9703897
[TBL] [Abstract][Full Text] [Related]
8. Role of hydrogen peroxide in cytotoxicity induction by ascorbates and other redox compounds.
Iwasaka K; Koyama N; Nogaki A; Maruyama S; Tamura A; Takano H; Takahama M; Kochi M; Satoh K; Sakagami H
Anticancer Res; 1998; 18(6A):4333-7. PubMed ID: 9891488
[TBL] [Abstract][Full Text] [Related]
9. Decline of superoxide dismutase activity during antioxidant-induced apoptosis in HL-60 cells.
Zhang W; Hashimoto K; Yu GY; Sakagami H
Anticancer Res; 2002; 22(1A):219-24. PubMed ID: 12017292
[TBL] [Abstract][Full Text] [Related]
10. Changes in intracellular concentrations of amino acids and polyamines during the apoptosis of HL-60 cells.
Sakagami H; Fujiwara E; Yokote Y; Akahane K; Asano K; Kochi M; Hara E; Shirahata A
Anticancer Res; 2000; 20(1A):265-70. PubMed ID: 10769665
[TBL] [Abstract][Full Text] [Related]
11. Modulating factors of radical intensity and cytotoxic activity of ascorbate (review).
Sakagami H; Satoh K
Anticancer Res; 1997; 17(5A):3513-20. PubMed ID: 9413196
[TBL] [Abstract][Full Text] [Related]
12. Copper, but not iron, enhances apoptosis-inducing activity of antioxidants.
Satoh K; Kadofuku T; Sakagami H
Anticancer Res; 1997; 17(4A):2487-90. PubMed ID: 9252668
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis-inducing activity of vitamin C and vitamin K.
Sakagami H; Satoh K; Hakeda Y; Kumegawa M
Cell Mol Biol (Noisy-le-grand); 2000 Feb; 46(1):129-43. PubMed ID: 10726979
[TBL] [Abstract][Full Text] [Related]
14. Ascorbic acid inhibits apoptosis induced by X irradiation in HL60 myeloid leukemia cells.
Witenberg B; Kletter Y; Kalir HH; Raviv Z; Fenig E; Nagler A; Halperin D; Fabian I
Radiat Res; 1999 Nov; 152(5):468-78. PubMed ID: 10521923
[TBL] [Abstract][Full Text] [Related]
15. L-Ascorbic acid induces apoptosis in acute myeloid leukemia cells via hydrogen peroxide-mediated mechanisms.
Park S; Han SS; Park CH; Hahm ER; Lee SJ; Park HK; Lee SH; Kim WS; Jung CW; Park K; Riordan HD; Kimler BF; Kim K; Lee JH
Int J Biochem Cell Biol; 2004 Nov; 36(11):2180-95. PubMed ID: 15313465
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial control of cell death induction by sodium 5,6-benzylidene-L-ascorbate.
Fujii H; Amano O; Kochi M; Sakagami H
Anticancer Res; 2003; 23(2B):1353-6. PubMed ID: 12820394
[TBL] [Abstract][Full Text] [Related]
17. Stability of sodium 5,6-benzylidene-L-ascorbate.
Sakagami H; Yamamura TS; Takahashi H; Shibuya I; Takeda M
Anticancer Res; 1995; 15(4):1269-74. PubMed ID: 7654007
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of the antitumor action between sodium 5,6-benzylidene-L-ascorbate and sodium ascorbate (minireview).
Sakagami H; Satoh K; Kochi M
Anticancer Res; 1997; 17(6D):4451-2. PubMed ID: 9494548
[TBL] [Abstract][Full Text] [Related]
19. Tumor-specific cytotoxicity and type of cell death induced by sodium 5,6-benzylidene-L-ascorbate.
Kishino K; Hashimoto K; Amano O; Kochi M; Liu WK; Sakagami H
Anticancer Res; 2008; 28(5A):2577-84. PubMed ID: 19035281
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of radical intensity and cytotoxic activity of ascorbate by hyperthermia.
Satoh K; Sakagami H; Nakamura K
Anticancer Res; 1996; 16(5A):2987-91. PubMed ID: 8917417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
